Infectious Diseases (all articles)
Immunization services begin slow recovery from COVID-19 disruptions, though millions of children remain at risk from deadly diseases – WHO, UNICEF, Gavi
27 Apr, 2021 | 08:41h | UTCRelated report: Disability considerations for COVID-19 vaccination: WHO and UNICEF policy brief, 19 April 2021 – World Health Organization
Commentary on Twitter
While immunization services begin slow recovery from #COVID19, millions of children around the 🌍🌏🌎 remain vulnerable to deadly diseases.
More info 👉https://t.co/YjskC8z6nc pic.twitter.com/SEv8d2VSAB
— World Health Organization (WHO) (@WHO) April 26, 2021
Why the World Should Worry About India – “The world’s largest vaccine producer is struggling to overcome its latest COVID-19 surge—and that’s everyone’s problem.”
27 Apr, 2021 | 08:33h | UTCWhy the World Should Worry About India – The Atlantic
See also: Covid-19: Countries rally to support India through “storm that has shaken the nation” – The BMJ AND As India breaks another global Covid-19 record and hospitals run out of oxygen, countries pledge assistance and aid – CNN AND India’s COVID-19 crisis prompts global response – CIDRAP
Study in nursing homes shows rapid antigen testing could be a useful tool to identify contagious people at risk for transmitting SARS-CoV-2
27 Apr, 2021 | 08:35h | UTCEditorial: Utility of Rapid Antigen Tests in Nursing Homes
Commentary on Twitter
💥🆕 Despite lower positive agreement compared with RT-PCR, antigen test positivity had higher agreement with shedding of replication-competent virus. These results suggest that antigen testing could be a useful tool to rapidly identify contagious people. https://t.co/Dlw7ttLlSL pic.twitter.com/sGmfVIy02H
— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) April 26, 2021
M-A: Prophylaxis against Covid-19: 1 – no benefit from Hydroxychloroquine; 2 – as studies on ivermectin so far have been small, it remains very uncertain whether ivermectin reduces SARS-CoV-2 infection
27 Apr, 2021 | 08:44h | UTCProphylaxis against covid-19: living systematic review and network meta-analysis – The BMJ
The Utility of Chest CT imaging in suspected or diagnosed COVID-19 Patients – a review of literature
27 Apr, 2021 | 08:30h | UTC
Opinion | Real-world data, not predictions, should drive decisions on Covid-19 and school opening
27 Apr, 2021 | 08:26h | UTCReal-world data, not predictions, should drive decisions on Covid-19 and school opening – STAT
Commentary from the author on Twitter
Real-world data, not predictions, should drive decisions on Covid-19 and school opening with @elbeezuchdt @citizen_oregon: Concept is simple. Schools are half/closed due to alarmist inaccurate models. Use real-world data to drive our decisions on kids.https://t.co/HfZl8IAVXq
— Monica Gandhi MD, MPH (@MonicaGandhi9) April 23, 2021
Clinical Manifestation, Evaluation, and Rehabilitative Strategy of Dysphagia Associated With COVID-19
27 Apr, 2021 | 08:29h | UTC
Covid-19: Infections fell by 65% after first dose of AstraZeneca or Pfizer vaccine, data show
25 Apr, 2021 | 22:06h | UTC
Commentary on Twitter (thread – click for more)
Over one year into the #COVID19 pandemic, about 9⃣0⃣% of countries surveyed still report one or more disruptions to essential health services. Major efforts are required to restore and strengthen services in all countries.
👉 https://t.co/P34xPKY1Io pic.twitter.com/UYDQPX67Vw
— World Health Organization (WHO) (@WHO) April 23, 2021
Clinical review of 43 patients with COVID-19-associated Acute Transverse Myelitis and 3 patients with Acute Transverse Myelitis reported post-vaccination
27 Apr, 2021 | 08:32h | UTCCommentary: Rare neurological condition linked to COVID-19 cases in 21 countries – Houston Methodist
SARS-CoV-2 and Stroke Characteristics – higher rate of large vessel occlusions and stroke in young patients
25 Apr, 2021 | 22:01h | UTC
Commentary on Twitter
SARS-CoV-2 and #Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group #COVID19 #AHACOVID19 #AHAJournals @cgriessenauer @ArKatsanos https://t.co/Errp6MjQMV pic.twitter.com/QX5tAGQOXU
— Stroke AHA/ASA (@StrokeAHA_ASA) April 21, 2021
Opinion | The International Community Has One Job: Getting COVID-19 Under Control
25 Apr, 2021 | 22:09h | UTC
Commentary on Twitter
India is in a crisis of unimaginable scale & predictable severity–and our international leadership is MIA and ready to move on. Pull it together & do your ONE JOB: getting the entire world out of the COVID mass casualty catastrophe.
w/@glassmanamanda https://t.co/0Xj3KZgUTh
— Rachel Bonnifield (@rachelbnfield) April 23, 2021
WHO chief – The world can bring the global COVID-19 pandemic under control in the coming months provided it distributes the necessary resources fairly
25 Apr, 2021 | 22:08h | UTCSee also: Opinion | I Run the W.H.O., and I Know That Rich Countries Must Make a Choice – The New York Times
Commentary on Twitter
We have all the tools to tame the #COVID19 pandemic everywhere in a matter of months. It comes down to a simple choice: to share or not to share. My piece on #VaccinEquity in the @nytimes. https://t.co/OIRAogZPwl
— Tedros Adhanom Ghebreyesus (@DrTedros) April 23, 2021
Recommendations to address patients fear of adverse effects and COVID-19 vaccine hesitancy
25 Apr, 2021 | 21:58h | UTC
WHO: COVID-19 continues to disrupt essential health services in 90% of countries
25 Apr, 2021 | 22:12h | UTC
Commentary on Twitter (thread – click for more)
Over one year into the #COVID19 pandemic, about 9⃣0⃣% of countries surveyed still report one or more disruptions to essential health services. Major efforts are required to restore and strengthen services in all countries.
👉 https://t.co/P34xPKY1Io pic.twitter.com/UYDQPX67Vw
— World Health Organization (WHO) (@WHO) April 23, 2021
U.S. lifts pause on use of J&J’s Covid-19 vaccine
25 Apr, 2021 | 21:57h | UTCU.S. lifts pause on use of J&J’s Covid-19 vaccine – STAT
See also: CDC, FDA lift pause on using J&J’s coronavirus vaccine, add safety warning – CNN AND ACIP opts to lift pause on Johnson & Johnson vaccine – CIDRAP
One million coronavirus sequences: popular genome site hits mega milestone
25 Apr, 2021 | 21:59h | UTCOne million coronavirus sequences: popular genome site hits mega milestone – Nature
Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal
25 Apr, 2021 | 21:17h | UTCNews release: Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal – University of Oxford
Original study (preprint): High Efficacy of a Low Dose Candidate Malaria Vaccine, R21 in 1 Adjuvant Matrix-M™, with Seasonal Administration to Children in Burkina Faso – The Lancet
Commentaries: Malaria vaccine hailed as potential breakthrough – BBC AND Oxford Malaria vaccine proves highly effective in Burkina Faso trial – The Guardian
Commentary on Twitter (thread – click for more)
💡AMAZING—First high >75% efficacy vaccine for a disease with 229 million cases & 409,000 deaths worldwide in 2019 —#Malaria!
Created by Oxford, produced by Serum Institute of India, & supporting adjuvant by Novavax, SII expects to make 200 mil doses a year!
Science! #vaccine pic.twitter.com/gnPMvXxww6
— Eric Feigl-Ding (@DrEricDing) April 23, 2021
Resurgence of SARS-CoV-2: detection by community viral surveillance
25 Apr, 2021 | 21:55h | UTCResurgence of SARS-CoV-2: detection by community viral surveillance – Science
Commentary on Twitter
A #SARSCoV2 surveillance program tested in England in 2020 successfully detected a resurgence of virus infection at low prevalence, @imperialcollege researchers say. Such programs can augment routine surveillance to inform public health interventions. https://t.co/veilAJ8YX4 pic.twitter.com/9YFQbvtqbw
— Science Magazine (@ScienceMagazine) April 23, 2021
Long Covid: Largest post-acute COVID-19 study to date examined the health outcomes in more than 73,000 people who’d had COVID-19 and were not hospitalized
23 Apr, 2021 | 08:48h | UTCHigh-dimensional characterization of post-acute sequalae of COVID-19 – Nature
Commentary on Twitter (thread – click for more)
Happy to share the latest paper from our team in @nature
A comprehensive characterization of post acute sequelae of COVID-19#longcovid #PASChttps://t.co/AGLnYCamWe@VAResearch @vahsrd @WUSTL @WUSTLpubhealth @WUSTLmed @WUSTLnews @VREFSTL @Biostayan @BCBowe
— Ziyad Al-Aly, MD (@zalaly) April 22, 2021
Recommendations on the Management of Maternal Hepatitis B, C and D Infection in Pregnancy
25 Apr, 2021 | 20:44h | UTC
Guideline: Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis)
25 Apr, 2021 | 20:47h | UTC
NIH Updates COVID-19 Treatment Guidelines – adds recommendations on colchicine, fluvoxamine, and monoclonal antibodies
23 Apr, 2021 | 08:46h | UTCNIH Coronavirus Disease 2019 (COVID-19)
Treatment Guidelines – National Institutes of Health
RCT: COVID outpatients don’t benefit from hydroxychloroquine, lopinavir-ritonavir
23 Apr, 2021 | 08:42h | UTCCOVID outpatients don’t benefit from hydroxychloroquine, lopinavir-ritonavir – CIDRAP
Commentary on Twitter (thread – Click for more)
1/ No benefit from Hydroxychloroquine or Lopinavir-Ritonavir on Hospitalization/Viral clearance for COVID-19 https://t.co/yhXxv26418 via @JAMANetworkOpen part of @JAMANetwork
— Priya Sampathkumar (@PSampathkumarMD) April 22, 2021
Case series of 18 male adults aged 50 years or younger with acute ischemic stroke during the convalescent phase of asymptomatic Covid-19
23 Apr, 2021 | 08:39h | UTC
Commentary on Twitter
A 💥🆕 case series highlights that adults 50 years or younger with asymptomatic COVID-19 infection diagnosed by positive SARS-CoV-2 serological test result may present with ischemic stroke during the convalescent phase of the infection
https://t.co/BVlo7Z1hgn @JAMANetworkOpen— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) April 22, 2021
Covid-19: More data on the increased risks to pregnant women and their newborn infants
23 Apr, 2021 | 08:44h | UTCEditorial: COVID-19 in Pregnant Women and Their Newborn Infants
Commentaries: Pregnant women with COVID-19 face high mortality rate – University of Washington School of Medicine AND Covid-19 raises risks for expectant mothers and babies, study says – CNN
Commentary on Twitter
18 country study in >2000 pregnant women with and without #COVID19 shows higher complication and death rates in symptomatic, but not asymptomatic, women with COVID-19. Their babies were at greater risk of neonatal complications, mainly due to preterm birth https://t.co/mRl8OOIMsz
— JAMA Pediatrics (@JAMAPediatrics) April 22, 2021


